Patents by Inventor TING-YUN SHEN

TING-YUN SHEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition and use of GMNL-263 in decreasing blood lipid levels
    Patent number: 9895400
    Abstract: A use of a Lactobacillus reuteri GMNL-263 in decreasing blood lipid levels is disclosed. Lactobacillus reuteri GMNL-263 (accession No.: CCTCC M 209263) specifically inhibits gene expression related to pro-inflammatory factor and lipid synthesis and promotes gene expression related to cholesterol metabolism. Lactobacillus reuteri GMNL-263 is utilized to produce a composition for decreasing blood lipid levels, thereby achieving the aim of hyperlipidemia treatment.
    Type: Grant
    Filed: February 10, 2015
    Date of Patent: February 20, 2018
    Assignee: Genmont Biotech Inc.
    Inventors: Yi-Hsing Chen, Ya-Hui Chen, Tzu-Chi Lou, Ting-Yun Shen
  • COMPOSITION AND USE OF LACTOBACILLUS REUTERI GMNL-263 IN DECREASING BLOOD LIPID LEVELS
    Publication number: 20160095889
    Abstract: A use of a Lactobacillus reuteri GMNL-263 in decreasing blood lipid levels is disclosed. Lactobacillus reuteri GMNL-263 (accession No.: CCTCC M 209263) specifically inhibits gene expression related to pro-inflammatory factor and lipid synthesis and promotes gene expression related to cholesterol metabolism. Lactobacillus reuteri GMNL-263 is utilized to produce a composition for decreasing blood lipid levels, thereby achieving the aim of hyperlipidemia treatment.
    Type: Application
    Filed: February 10, 2015
    Publication date: April 7, 2016
    Inventors: YI-HSING CHEN, YA-HUI CHEN, TZU-CHI LOU, TING-YUN SHEN